A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular Lymphoma

NCT06097364 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

733

Enrollment

INDUSTRY

Sponsor class

Conditions

Follicular Lymphoma (FL)

Interventions

DRUG: Odronextamab
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Prednisone/Prenisolone

Sponsor

Regeneron Pharmaceuticals